Tuesday, February 28, 2017 10:53:42 AM
MBOT MicroBot...interesting company but I don't know if its safe to chase price right now...I'd like to see that recent gap filled...
Put on speculation with a buy 1/3 position and maybe get another drawback...
Above $4.40 is a buy...
Microbot Medical Inc., a medical device company, engages in the research, design, development, and commercialization of micro-robotics medical technologies. Its ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel
http://finance.yahoo.com/news/microbot-medical-inc-announces-research-120000588.html
Microbot Medical self-cleaning shunt (SCS), a device which is designed to prevent obstruction in the cerebrospinal fluid (CSF) catheters implanted in the ventricle of the brain of patients who suffer from hydrocephalus or Normal Pressure Hydrocephalus (NPH).
Hydrocephalus is a condition which causes an excessive accumulation of fluid in the brain and effects one out of every 500 infants born in the United States alone every year while NPH is a condition that typically develops over time and effects the elderly population. The primary objective of these pre-clinical studies is to determine the safety and effectiveness of the Company’s SCS device to prevent obstruction in CSF catheters in clinically relevant in vivo studies.
60minute
MBOT MicroBot Medical
Put on speculation with a buy 1/3 position and maybe get another drawback...
Above $4.40 is a buy...
Microbot Medical Inc., a medical device company, engages in the research, design, development, and commercialization of micro-robotics medical technologies. Its ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel
http://finance.yahoo.com/news/microbot-medical-inc-announces-research-120000588.html
Microbot Medical self-cleaning shunt (SCS), a device which is designed to prevent obstruction in the cerebrospinal fluid (CSF) catheters implanted in the ventricle of the brain of patients who suffer from hydrocephalus or Normal Pressure Hydrocephalus (NPH).
Hydrocephalus is a condition which causes an excessive accumulation of fluid in the brain and effects one out of every 500 infants born in the United States alone every year while NPH is a condition that typically develops over time and effects the elderly population. The primary objective of these pre-clinical studies is to determine the safety and effectiveness of the Company’s SCS device to prevent obstruction in CSF catheters in clinically relevant in vivo studies.
60minute
MBOT MicroBot Medical
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
